Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 136


Liver Diseases in the Perinatal Period: Interactions between Mother and Infant.

Ibrahim SH, Jonas MM, Taylor SA, Gutierrez Sanchez LH, Wolf JL, Sundaram SS.

Hepatology. 2020 Jan 10. doi: 10.1002/hep.31109. [Epub ahead of print] Review.


Hepatitis C Guidance 2019 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection.

Ghany MG, Marks KM, Morgan TR, Wyles DL, Aronsohn AI, Bhattacharya D, Broder T, Falade-Nwulia OO, Feld JJ, Gordon SC, Heller T, Jhaveri RR, Jonas MM, Kiser JJ, Linas BP, Lo Re V, Peters MG, Reddy KR, Reynolds A, Scott JD, Searson G, Spradling P, Terrault NA, Trooskin SB, Verna EC, Wong JB, Woolley AE, Workowski KA.

Hepatology. 2019 Dec 9. doi: 10.1002/hep.31060. [Epub ahead of print]


Esophageal Capsule Endoscopy in Children and Young Adults With Portal Hypertension.

Pai AK, Jonas MM, Fox VL.

J Pediatr Gastroenterol Nutr. 2019 Dec;69(6):641-647. doi: 10.1097/MPG.0000000000002455.


Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Adolescents With Chronic Hepatitis C Virus: Part 1 of the DORA Study.

Jonas MM, Squires RH, Rhee SM, Lin CW, Bessho K, Feiterna-Sperling C, Hierro L, Kelly D, Ling SC, Strokova T, Del Valle-Segarra A, Lovell S, Liu W, Ng TI, Porcalla A, Gonzalez YS, Burroughs M, Sokal E.

Hepatology. 2019 Jun 29. doi: 10.1002/hep.30840. [Epub ahead of print]


Sofosbuvir and Ribavirin Therapy for Children Aged 3 to <12 Years With Hepatitis C Virus Genotype 2 or 3 Infection.

Rosenthal P, Schwarz KB, Gonzalez-Peralta RP, Lin CH, Kelly DA, Nightingale S, Balistreri WF, Bansal S, Jonas MM, Massetto B, Brainard DM, Hsueh CH, Shao J, Parhy B, Davison S, Feiterna-Sperling C, Gillis LA, Indolfi G, Sokal EM, Murray KF, Wirth S.

Hepatology. 2020 Jan;71(1):31-43. doi: 10.1002/hep.30821. Epub 2019 Aug 13.


Update on Prevention, Diagnosis, and Treatment of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance.

Terrault NA, Lok ASF, McMahon BJ, Chang KM, Hwang JP, Jonas MM, Brown RS Jr, Bzowej NH, Wong JB.

Clin Liver Dis (Hoboken). 2018 Aug 22;12(1):33-34. doi: 10.1002/cld.728. eCollection 2018 Jul. Review. No abstract available.


Hepatitis B virus infection in children and adolescents.

Indolfi G, Easterbrook P, Dusheiko G, Siberry G, Chang MH, Thorne C, Bulterys M, Chan PL, El-Sayed MH, Giaquinto C, Jonas MM, Meyers T, Walsh N, Wirth S, Penazzato M.

Lancet Gastroenterol Hepatol. 2019 Jun;4(6):466-476. doi: 10.1016/S2468-1253(19)30042-1. Epub 2019 Apr 11. Review.


Hepatitis C virus infection in children and adolescents.

Indolfi G, Easterbrook P, Dusheiko G, El-Sayed MH, Jonas MM, Thorne C, Bulterys M, Siberry G, Walsh N, Chang MH, Meyers T, Giaquinto C, Wirth S, Chan PL, Penazzato M.

Lancet Gastroenterol Hepatol. 2019 Jun;4(6):477-487. doi: 10.1016/S2468-1253(19)30046-9. Epub 2019 Apr 11. Review.


Effect of Universal Infant Hepatitis B Virus Immunization on Mother-to-Child Hepatitis B Virus Transmission.

Nastasio S, Jonas MM.

J Infect Dis. 2019 Aug 30;220(7):1089-1090. doi: 10.1093/infdis/jiy707. No abstract available.


Controlled attenuation parameter: A measure of hepatic steatosis in patients with cystic fibrosis.

Bader RM, Jonas MM, Mitchell PD, Wiggins S, Lee CK.

J Cyst Fibros. 2019 Mar;18(2):280-285. doi: 10.1016/j.jcf.2018.11.004. Epub 2018 Dec 1.


Ombitasvir/Paritaprevir/Ritonavir With or Without Dasabuvir and With or Without Ribavirin for Adolescents With HCV Genotype 1 or 4.

Leung DH, Wirth S, Yao BB, Viani RM, Gonzalez-Peralta RP, Jonas MM, Lobritto SJ, Narkewicz MR, Sokal E, Fortuny C, Hsu EK, Del Valle-Segarra A, Zha J, Larsen L, Liu L, Shuster DL, Cohen DE, Rosenthal P.

Hepatol Commun. 2018 Oct 5;2(11):1311-1319. doi: 10.1002/hep4.1250. eCollection 2018 Nov.


Hepatotoxicity of Statins as Determined by Serum Alanine Aminotransferase in a Pediatric Cohort With Dyslipidemia.

Desai NK, Mendelson MM, Baker A, Ryan HH, Griggs S, Boghani M, Yellen E, Buckley L, Gillman MW, Zachariah JP, Graham D, Jonas MM, de Ferranti SD.

J Pediatr Gastroenterol Nutr. 2019 Feb;68(2):175-181. doi: 10.1097/MPG.0000000000002174.


Universal Screening of Pregnant Women for Hepatitis C: The Time Is Now.

Jhaveri R, Broder T, Bhattacharya D, Peters MG, Kim AY, Jonas MM.

Clin Infect Dis. 2018 Oct 30;67(10):1493-1497. doi: 10.1093/cid/ciy586.


Safety and Efficacy of Ledipasvir-Sofosbuvir With or Without Ribavirin for Chronic Hepatitis C in Children Ages 6-11.

Murray KF, Balistreri WF, Bansal S, Whitworth S, Evans HM, Gonzalez-Peralta RP, Wen J, Massetto B, Kersey K, Shao J, Garrison KL, Parhy B, Brainard DM, Arnon R, Gillis LA, Jonas MM, Lin CH, Narkewicz MR, Schwarz K, Rosenthal P.

Hepatology. 2018 Dec;68(6):2158-2166. doi: 10.1002/hep.30123. Epub 2018 Nov 17.



Terrault NA, Brown RS Jr, Lok AS, Wong JB, Bzowej NH, Chang KM, Hwang JP, Jonas MM, McMahon BJ.

Hepatology. 2018 Oct;68(4):1658-1660. doi: 10.1002/hep.30137. No abstract available.


Validation of Transient Elastography Cut Points to Assess Advanced Liver Fibrosis in Children and Young Adults: The Boston Children's Hospital Experience.

Lee CK, Mitchell PD, Raza R, Harney S, Wiggins SM, Jonas MM.

J Pediatr. 2018 Jul;198:84-89.e2. doi: 10.1016/j.jpeds.2018.02.062.


Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance.

Terrault NA, Lok ASF, McMahon BJ, Chang KM, Hwang JP, Jonas MM, Brown RS Jr, Bzowej NH, Wong JB.

Hepatology. 2018 Apr;67(4):1560-1599. doi: 10.1002/hep.29800. No abstract available.


Liver Failure as the Presentation of Ornithine Transcarbamylase Deficiency in a 13-Month-Old Female.

Rajabi F, Rodan LH, Jonas MM, Soul JS, Ullrich NJ, Wessel A, Waisbren SE, Tan WH, Berry GT.

JIMD Rep. 2018;40:17-22. doi: 10.1007/8904_2017_55. Epub 2017 Sep 9.


Sofosbuvir and ribavirin in adolescents 12-17 years old with hepatitis C virus genotype 2 or 3 infection.

Wirth S, Rosenthal P, Gonzalez-Peralta RP, Jonas MM, Balistreri WF, Lin CH, Hardikar W, Kersey K, Massetto B, Kanwar B, Brainard DM, Shao J, Svarovskaia E, Kirby B, Arnon R, Murray KF, Schwarz KB.

Hepatology. 2017 Oct;66(4):1102-1110. doi: 10.1002/hep.29278. Epub 2017 Aug 26.


The safety and effectiveness of ledipasvir-sofosbuvir in adolescents 12-17 years old with hepatitis C virus genotype 1 infection.

Balistreri WF, Murray KF, Rosenthal P, Bansal S, Lin CH, Kersey K, Massetto B, Zhu Y, Kanwar B, German P, Svarovskaia E, Brainard DM, Wen J, Gonzalez-Peralta RP, Jonas MM, Schwarz K.

Hepatology. 2017 Aug;66(2):371-378. doi: 10.1002/hep.28995. Epub 2017 Jun 19.


Hepatic Issues and Complications Associated With Inflammatory Bowel Disease: A Clinical Report From the NASPGHAN Inflammatory Bowel Disease and Hepatology Committees.

Saubermann LJ, Deneau M, Falcone RA, Murray KF, Ali S, Kohli R, Ekong UD, Valentino PL, Grossman AB, Rand EB, Jonas MM, Saeed SA, Kamath BM.

J Pediatr Gastroenterol Nutr. 2017 Apr;64(4):639-652. doi: 10.1097/MPG.0000000000001492. Review.


Correlation of Transient Elastography With Severity of Cystic Fibrosis-related Liver Disease.

Aqul A, Jonas MM, Harney S, Raza R, Sawicki GS, Mitchell PD, Fawaz R.

J Pediatr Gastroenterol Nutr. 2017 Apr;64(4):505-511. doi: 10.1097/MPG.0000000000001448.


Hepatic Inflammation May Influence Liver Stiffness Measurements by Transient Elastography in Children and Young Adults.

Raizner A, Shillingford N, Mitchell PD, Harney S, Raza R, Serino J, Jonas MM, Lee CK.

J Pediatr Gastroenterol Nutr. 2017 Apr;64(4):512-517. doi: 10.1097/MPG.0000000000001376.


The Natural History of Primary Sclerosing Cholangitis in Children: A Large Single-Center Longitudinal Cohort Study.

Valentino PL, Wiggins S, Harney S, Raza R, Lee CK, Jonas MM.

J Pediatr Gastroenterol Nutr. 2016 Dec;63(6):603-609.


Outcomes after discontinuation of routine use of transanastomotic biliary stents in pediatric liver transplantation at a single site.

Valentino PL, Jonas MM, Lee CK, Kim HB, Vakili K, Elisofon SA.

Pediatr Transplant. 2016 Aug;20(5):647-51. doi: 10.1111/petr.12729. Epub 2016 May 30.


Comparison of Controlled Attenuation Parameter and Liver Biopsy to Assess Hepatic Steatosis in Pediatric Patients.

Desai NK, Harney S, Raza R, Al-Ibraheemi A, Shillingford N, Mitchell PD, Jonas MM.

J Pediatr. 2016 Jun;173:160-164.e1. doi: 10.1016/j.jpeds.2016.03.021. Epub 2016 Mar 30.


Hepatitis C: Issues in Children.

Lee CK, Jonas MM.

Gastroenterol Clin North Am. 2015 Dec;44(4):901-9. doi: 10.1016/j.gtc.2015.07.011. Epub 2015 Aug 13. Review.


Antiviral therapy in management of chronic hepatitis B viral infection in children: A systematic review and meta-analysis.

Jonas MM, Lok AS, McMahon BJ, Brown RS Jr, Wong JB, Ahmed AT, Farah W, Mouchli MA, Singh S, Prokop LJ, Murad MH, Mohammed K.

Hepatology. 2016 Jan;63(1):307-18. doi: 10.1002/hep.28278. Epub 2015 Nov 13. Review.


AASLD guidelines for treatment of chronic hepatitis B.

Terrault NA, Bzowej NH, Chang KM, Hwang JP, Jonas MM, Murad MH; American Association for the Study of Liver Diseases.

Hepatology. 2016 Jan;63(1):261-83. doi: 10.1002/hep.28156. Epub 2015 Nov 13. No abstract available.


Durability of Response in Children Treated With Pegylated Interferon alfa [corrected] 2a ± Ribavirin for Chronic Hepatitis C.

Schwarz KB, Molleston JP, Jonas MM, Wen J, Murray KF, Rosenthal P, Gonzalez-Peralta RP, Lobritto SJ, Mogul D, Pavlovic V, Warne C, Wat C, Thompson B.

J Pediatr Gastroenterol Nutr. 2016 Jan;62(1):93-6. doi: 10.1097/MPG.0000000000000929. Erratum in: J Pediatr Gastroenterol Nutr. 2016 Feb;62(2):357. J Pediatr Gastroenterol Nutr. 2016 Jan 11;:.


Randomized, controlled trial of entecavir versus placebo in children with hepatitis B envelope antigen-positive chronic hepatitis B.

Jonas MM, Chang MH, Sokal E, Schwarz KB, Kelly D, Kim KM, Ling SC, Rosenthal P, Oraseanu D, Reynolds L, Thiry A, Ackerman P.

Hepatology. 2016 Feb;63(2):377-87. doi: 10.1002/hep.28015. Epub 2015 Oct 16. Erratum in: Hepatology. 2017 Apr;65(4):1427.


Portal and centrilobular hepatic fibrosis in Fontan circulation and clinical outcomes.

Wu FM, Jonas MM, Opotowsky AR, Harmon A, Raza R, Ukomadu C, Landzberg MJ, Singh MN, Valente AM, Egidy Assenza G, Perez-Atayde AR.

J Heart Lung Transplant. 2015 Jul;34(7):883-91. doi: 10.1016/j.healun.2015.01.993. Epub 2015 Feb 11.


Treating HCV infection in children.

Lee CK, Jonas MM.

Clin Liver Dis (Hoboken). 2015 Mar 4;5(1):14-16. doi: 10.1002/cld.439. eCollection 2015 Jan. Review. No abstract available.


Hyaline droplets in Kupffer cells: a novel diagnostic clue for autoimmune hepatitis.

Tucker SM, Jonas MM, Perez-Atayde AR.

Am J Surg Pathol. 2015 Jun;39(6):772-8. doi: 10.1097/PAS.0000000000000395.


Correlates of adiponectin in hepatitis C-infected children: the importance of body mass index.

Delgado-Borrego A, Gonzalez-Peralta RP, Raza R, Negre B, Goodman ZD, Jonas MM, Chung RT, Ludwig DA; PEDS-C Clinical Research Network.

J Pediatr Gastroenterol Nutr. 2015 Feb;60(2):165-70. doi: 10.1097/MPG.0000000000000604.


Long-term growth outcomes in children treated for chronic hepatitis C.

Jonas MM, Schwarz KB, Gonzalez-Peralta R, Lobritto S, Molleston JP, Murray KF, Rosenthal P, Wen J, Wat C, Pavlovic V, Warne C.

J Pediatr. 2014 Dec;165(6):1252-4. doi: 10.1016/j.jpeds.2014.08.010. Epub 2014 Sep 17.


Transient elastography may identify Fontan patients with unfavorable hemodynamics and advanced hepatic fibrosis.

Wu FM, Opotowsky AR, Raza R, Harney S, Ukomadu C, Landzberg MJ, Valente AM, Breitbart RE, Singh MN, Gauvreau K, Jonas MM.

Congenit Heart Dis. 2014 Sep-Oct;9(5):438-47. doi: 10.1111/chd.12159. Epub 2014 Jan 13.


Sonography-guided percutaneous liver biopsies in children.

Govender P, Jonas MM, Alomari AI, Padua HM, Dillon BJ, Landrigan-Ossar MF, Chaudry G.

AJR Am J Roentgenol. 2013 Sep;201(3):645-50. doi: 10.2214/AJR.12.9802.


Serum biomarkers and transient elastography as predictors of advanced liver fibrosis in a United States cohort: the Boston children's hospital experience.

Lee CK, Perez-Atayde AR, Mitchell PD, Raza R, Afdhal NH, Jonas MM.

J Pediatr. 2013 Oct;163(4):1058-64.e2. doi: 10.1016/j.jpeds.2013.04.044. Epub 2013 Jun 5.


A low-glycemic-load versus low-fat diet in the treatment of fatty liver in obese children.

Ramon-Krauel M, Salsberg SL, Ebbeling CB, Voss SD, Mulkern RV, Apura MM, Cooke EA, Sarao K, Jonas MM, Ludwig DS.

Child Obes. 2013 Jun;9(3):252-60. doi: 10.1089/chi.2013.0022. Epub 2013 May 24.


Hepatitis B virus infection in children.

Jonas MM.

Clin Liver Dis (Hoboken). 2013 Mar 1;2(1):41-44. doi: 10.1002/cld.125. eCollection 2013 Feb. Review. No abstract available.


Autoantibodies and autoimmune disease during treatment of children with chronic hepatitis C.

Molleston JP, Mellman W, Narkewicz MR, Balistreri WF, Gonzalez-Peralta RP, Jonas MM, Lobritto SJ, Mohan P, Murray KF, Njoku D, Rosenthal P, Barton BA, Talor MV, Cheng I, Schwarz KB, Haber BA; PEDS-C Clinical Research Network.

J Pediatr Gastroenterol Nutr. 2013 Mar;56(3):304-10. doi: 10.1097/MPG.0b013e3182774cae.


Expected and actual case ascertainment and treatment rates for children infected with hepatitis C in Florida and the United States: epidemiologic evidence from statewide and nationwide surveys.

Delgado-Borrego A, Smith L, Jonas MM, Hall CA, Negre B, Jordan SH, Ogrodowicz M, Raza R, Ludwig DA, Miller T, Lipshultz SE, Gonzalez-Peralta R, Chung RT.

J Pediatr. 2012 Nov;161(5):915-21. doi: 10.1016/j.jpeds.2012.05.002. Epub 2012 Jul 3.


Multivisceral transplantation using a 2.9 kg neonatal donor.

Cauley RP, Suh MY, Kamin DS, Lillehei CW, Jenkins RL, Jonas MM, Vakili K, Kim HB.

Pediatr Transplant. 2012 Dec;16(8):E379-82. doi: 10.1111/j.1399-3046.2012.01739.x. Epub 2012 Jun 13.


Efficacy and safety of long-term adefovir dipivoxil therapy in children with chronic hepatitis B infection.

Jonas MM, Kelly D, Pollack H, Mizerski J, Sorbel J, Frederick D, Mondou E, Rousseau F, Sokal E.

Pediatr Infect Dis J. 2012 Jun;31(6):578-82. doi: 10.1097/INF.0b013e318255ffe7.


Durability of sustained response shown in paediatric patients with chronic hepatitis C who were treated with interferon alfa-2b plus ribavirin.

Kelly DA, Haber B, González-Peralta RP, Murray KF, Jonas MM, Molleston JP, Narkewicz MR, Sinatra FR, Lang T, Lachaux A, Wirth S, Shelton M, Te HS, Pollack H, Deng W, Noviello S, Albrecht JK.

J Viral Hepat. 2012 Apr;19(4):263-70. doi: 10.1111/j.1365-2893.2011.01544.x. Epub 2011 Nov 17.


Pegylated interferon for chronic hepatitis C in children affects growth and body composition: results from the pediatric study of hepatitis C (PEDS-C) trial.

Jonas MM, Balistreri W, Gonzalez-Peralta RP, Haber B, Lobritto S, Mohan P, Molleston JP, Murray KF, Narkewicz MR, Rosenthal P, Schwarz KB, Barton BA, Shepherd JA, Mitchell PD, Duggan C.

Hepatology. 2012 Aug;56(2):523-31. doi: 10.1002/hep.25690. Epub 2012 Jul 6.


Hepatitis A virus infection: progress made, more work to be done.

Jonas MM.

J Pediatr (Rio J). 2011 May-Jun 8;87(3):185-6. doi: 10.2223/JPED.2106. English, Portuguese. No abstract available.


Peginterferon with or without ribavirin has minimal effect on quality of life, behavioral/emotional, and cognitive outcomes in children.

Rodrigue JR, Balistreri W, Haber B, Jonas MM, Mohan P, Molleston JP, Murray KF, Narkewicz MR, Rosenthal P, Smith LJ, Lobritto SJ, Schwarz KB, Robuck PR, Barton B, González-Peralta RP.

Hepatology. 2011 May;53(5):1468-75. doi: 10.1002/hep.24248.


The combination of ribavirin and peginterferon is superior to peginterferon and placebo for children and adolescents with chronic hepatitis C.

Schwarz KB, Gonzalez-Peralta RP, Murray KF, Molleston JP, Haber BA, Jonas MM, Rosenthal P, Mohan P, Balistreri WF, Narkewicz MR, Smith L, Lobritto SJ, Rossi S, Valsamakis A, Goodman Z, Robuck PR, Barton BA; Peds-C Clinical Research Network.

Gastroenterology. 2011 Feb;140(2):450-458.e1. doi: 10.1053/j.gastro.2010.10.047. Epub 2010 Oct 28.

Supplemental Content

Loading ...
Support Center